Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)

There is an unmet need for new treatments for idiopathic pulmonary fibrosis (IPF). The oral preferential phosphodiesterase 4B inhibitor, BI 1015550, prevented a decline in forced vital capacity (FVC) in a phase II study in patients with IPF. This study design describes the subsequent pivotal phase I...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Richeldi, Luca (VerfasserIn) , Azuma, Arata (VerfasserIn) , Cottin, Vincent (VerfasserIn) , Kreuter, Michael (VerfasserIn) , Maher, Toby M. (VerfasserIn) , Martinez, Fernando J. (VerfasserIn) , Oldham, Justin M. (VerfasserIn) , Valenzuela, Claudia (VerfasserIn) , Gordat, Maud (VerfasserIn) , Liu, Yi (VerfasserIn) , Stowasser, Susanne (VerfasserIn) , Zoz, Donald F. (VerfasserIn) , Wijsenbeek, Marlies S. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: August 18, 2023
In: BMJ Open Respiratory Research
Year: 2023, Jahrgang: 10, Pages: 1-8
ISSN:2052-4439
DOI:10.1136/bmjresp-2022-001563
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1136/bmjresp-2022-001563
Verlag, kostenfrei, Volltext: https://bmjopenrespres.bmj.com/content/10/1/e001563
Volltext
Verfasserangaben:Luca Richeldi, Arata Azuma, Vincent Cottin, Michael Kreuter, Toby M. Maher, Fernando J. Martinez, Justin M. Oldham, Claudia Valenzuela, Maud Gordat, Yi Liu, Susanne Stowasser, Donald F. Zoz, Marlies S. Wijsenbeek

MARC

LEADER 00000caa a2200000 c 4500
001 1863789502
003 DE-627
005 20240307050448.0
007 cr uuu---uuuuu
008 231013s2023 xx |||||o 00| ||eng c
024 7 |a 10.1136/bmjresp-2022-001563  |2 doi 
035 |a (DE-627)1863789502 
035 |a (DE-599)KXP1863789502 
035 |a (OCoLC)1425210355 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Richeldi, Luca  |e VerfasserIn  |0 (DE-588)116026578X  |0 (DE-627)1023418843  |0 (DE-576)505817535  |4 aut 
245 1 0 |a Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)  |c Luca Richeldi, Arata Azuma, Vincent Cottin, Michael Kreuter, Toby M. Maher, Fernando J. Martinez, Justin M. Oldham, Claudia Valenzuela, Maud Gordat, Yi Liu, Susanne Stowasser, Donald F. Zoz, Marlies S. Wijsenbeek 
264 1 |c August 18, 2023 
300 |b Illustrationen 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 28.11.2023 
520 |a There is an unmet need for new treatments for idiopathic pulmonary fibrosis (IPF). The oral preferential phosphodiesterase 4B inhibitor, BI 1015550, prevented a decline in forced vital capacity (FVC) in a phase II study in patients with IPF. This study design describes the subsequent pivotal phase III study of BI 1015550 in patients with IPF (FIBRONEER-IPF). 
650 4 |a Lung Transplantation 
700 1 |a Azuma, Arata  |e VerfasserIn  |4 aut 
700 1 |a Cottin, Vincent  |e VerfasserIn  |4 aut 
700 1 |a Kreuter, Michael  |d 1972-  |e VerfasserIn  |0 (DE-588)122645995  |0 (DE-627)082066795  |0 (DE-576)293362742  |4 aut 
700 1 |a Maher, Toby M.  |e VerfasserIn  |4 aut 
700 1 |a Martinez, Fernando J.  |e VerfasserIn  |4 aut 
700 1 |a Oldham, Justin M.  |e VerfasserIn  |4 aut 
700 1 |a Valenzuela, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Gordat, Maud  |e VerfasserIn  |4 aut 
700 1 |a Liu, Yi  |e VerfasserIn  |4 aut 
700 1 |a Stowasser, Susanne  |e VerfasserIn  |4 aut 
700 1 |a Zoz, Donald F.  |e VerfasserIn  |4 aut 
700 1 |a Wijsenbeek, Marlies S.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t BMJ Open Respiratory Research  |d London : BMJ Publishing Group, 2013  |g 10(2023), Artikel-ID e001563, Seite 1-8  |h Online-Ressource  |w (DE-627)770027695  |w (DE-600)2736454-9  |w (DE-576)39440582X  |x 2052-4439  |7 nnas  |a Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF) 
773 1 8 |g volume:10  |g year:2023  |g elocationid:e001563  |g pages:1-8  |g extent:8  |a Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF) 
856 4 0 |u https://doi.org/10.1136/bmjresp-2022-001563  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://bmjopenrespres.bmj.com/content/10/1/e001563  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20231013 
993 |a Article 
994 |a 2023 
998 |g 122645995  |a Kreuter, Michael  |m 122645995:Kreuter, Michael  |d 50000  |e 50000PK122645995  |k 0/50000/  |p 4 
999 |a KXP-PPN1863789502  |e 4387052392 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)","title_sort":"Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)"}],"id":{"eki":["1863789502"],"doi":["10.1136/bmjresp-2022-001563"]},"name":{"displayForm":["Luca Richeldi, Arata Azuma, Vincent Cottin, Michael Kreuter, Toby M. Maher, Fernando J. Martinez, Justin M. Oldham, Claudia Valenzuela, Maud Gordat, Yi Liu, Susanne Stowasser, Donald F. Zoz, Marlies S. Wijsenbeek"]},"physDesc":[{"extent":"8 S.","noteIll":"Illustrationen"}],"origin":[{"dateIssuedDisp":"August 18, 2023","dateIssuedKey":"2023"}],"relHost":[{"title":[{"title":"BMJ Open Respiratory Research","title_sort":"BMJ Open Respiratory Research"}],"language":["eng"],"disp":"Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with idiopathic pulmonary fibrosis (FIBRONEER-IPF)BMJ Open Respiratory Research","name":{"displayForm":["British Thoracic Society"]},"origin":[{"publisher":"BMJ Publishing Group","dateIssuedDisp":"2013-","publisherPlace":"London","dateIssuedKey":"2013"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["2052-4439"],"zdb":["2736454-9"],"eki":["770027695"]},"recId":"770027695","part":{"volume":"10","text":"10(2023), Artikel-ID e001563, Seite 1-8","year":"2023","extent":"8","pages":"1-8"},"note":["Gesehen am 22.05.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["2013 -"]}],"person":[{"given":"Luca","role":"aut","roleDisplay":"VerfasserIn","display":"Richeldi, Luca","family":"Richeldi"},{"given":"Arata","role":"aut","roleDisplay":"VerfasserIn","display":"Azuma, Arata","family":"Azuma"},{"given":"Vincent","role":"aut","roleDisplay":"VerfasserIn","display":"Cottin, Vincent","family":"Cottin"},{"display":"Kreuter, Michael","role":"aut","roleDisplay":"VerfasserIn","given":"Michael","family":"Kreuter"},{"given":"Toby M.","roleDisplay":"VerfasserIn","role":"aut","display":"Maher, Toby M.","family":"Maher"},{"given":"Fernando J.","roleDisplay":"VerfasserIn","role":"aut","display":"Martinez, Fernando J.","family":"Martinez"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Justin M.","display":"Oldham, Justin M.","family":"Oldham"},{"family":"Valenzuela","display":"Valenzuela, Claudia","given":"Claudia","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Gordat","display":"Gordat, Maud","given":"Maud","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Yi","role":"aut","roleDisplay":"VerfasserIn","display":"Liu, Yi","family":"Liu"},{"role":"aut","roleDisplay":"VerfasserIn","given":"Susanne","display":"Stowasser, Susanne","family":"Stowasser"},{"family":"Zoz","role":"aut","roleDisplay":"VerfasserIn","given":"Donald F.","display":"Zoz, Donald F."},{"given":"Marlies S.","role":"aut","roleDisplay":"VerfasserIn","display":"Wijsenbeek, Marlies S.","family":"Wijsenbeek"}],"language":["eng"],"note":["Gesehen am 28.11.2023"],"recId":"1863789502","type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a RICHELDILUDESIGNOFAP1820